Navigation Links
GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding
Date:1/19/2009

(Nonprofits Receive the GlaxoSmithKline 12th Annual IMPACT Awards)

PHILADELPHIA, Jan. 19 /PRNewswire/ -- GlaxoSmithKline, one of the world's leading research-based pharmaceutical and healthcare companies, has announced the recipients of the GlaxoSmithKline 12th Annual IMPACT Awards for providing access to community healthcare services. Each Pennsylvania-based nonprofit will receive a $40,000 award. A ceremony will be held on Tuesday, March 17 at GlaxoSmithKline in Philadelphia where grants will go to:

  • Breastfeeding Resource Center (Montgomery County);
  • Casa Guadalupe Center (Lehigh County);
  • Co-County Wellness Services (Berks County);
  • ElderNet of Lower Merion and Narberth (Montgomery County);
  • Family and Community Service of Delaware County;
  • Libertae, Inc. (Bucks County);
  • Public Citizens for Children and Youth (Philadelphia);
  • Resources for Children's Health (Philadelphia);
  • St. Catherine Laboure Medical Clinic (Philadelphia); and
  • Southeast Asian Mutual Assistance Associations Coalition (Philadelphia).

"All of the GlaxoSmithKline 12th Annual IMPACT Award winners are committed to the idea that everyone should have better access to healthcare and that no one should fall through the cracks. These organizations are on the front lines as change agents, working to build stronger and healthier communities. They are all deeply committed to their work and clients," said Mary Linda Andrews, GlaxoSmithKline Director, Community Partnerships.

Breastfeeding Resource Center, located in Glenside, Pa., provides expert clinical breastfeeding services to families, regardless of income, and serves as a resource for evidence-based breastfeeding information for healthcare professionals ('/>"/>

SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance : – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases –
2. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
3. GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program
4. GlaxoSmithKline to Acquire the Leading Dry Mouth Brand, Biotene
5. AUDIO from Medialink and GlaxoSmithKline: Give Kids A Boost For Their Health!
6. GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World Leader in Sirtuin Research and Development
7. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
8. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
9. Video: GlaxoSmithKline Consumer Healthcare Offers Free Nicotine Lozenges for All Certified Pilots and Air Traffic Controllers to Help Them Safely Quit Smoking
10. GlaxoSmithKline Announces $500,000 in Fellowships at Stanford Graduate School of Business
11. IADR and GlaxoSmithKline Consumer Healthcare announce winners

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...,, CARLSBAD,Calif.,Nov.23/PRNewswire-FirstCa..., Iwouldliketostartbythankingyouforyourcontinuing...ulmomentsinourhistory.Wearetrulyattheendofthebegin...yplatform,whichwebelieveaddressesmanyoftheissuesha...ispredicatedlargelyuponthesuccessofourflagshipdrug...
(Date:11/23/2009)...,, SANDIEGO,Calif.,Nov.23/PRNewswire-FirstCa...)todayannouncedthatfourseniorexecutiveshavejoinedt...sdrivingthedevelopmentofitsobesityfranchise.Additi...dofGlobalRegulatoryAffairs;SuzanneMcDonald,HeadofM....D.,HeadofGlobalContraveProgram;andWhedyWang,Ph.D,...
(Date:11/23/2009)..., Baptist Cardiovascular ...Jackson, Miss., is proud to announce the addition ... to its latest advancement in the treatment of pat... and clinicians breathe easier. , ...-- For heart failure patients suffering from fluid...
(Date:11/23/2009)...,, NORTHANDOVER,Mass.,Nov.23/PRNewswire/--Th...stressandanxiety.Oftenthesefeelings,bothpositivean...g;andlet,sfaceit,therearelotsofopportunitiestodoso...eonepieceofmom,sapplepie,buthowmanyofusstopthere?"...ushavespentholidayseasonafterholidayseasontellingo...
(Date:11/23/2009)..., Summary: People are hir...sonalities. Personality assessments give insight i...formance. The Candidate Potential Report assesses ... summarizes the recommendation for job fit and pot...aybrook, CT (PRWEB) November 23, 2009 -- When does...
Breaking Medicine News(10 mins):Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 2Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 3Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 4Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 5Health News:Baptist Cardiovascular Services Introduces New Technology for Congestive Heart Failure Treatment 2Health News:Baptist Cardiovascular Services Introduces New Technology for Congestive Heart Failure Treatment 3Health News:Tis' the Season to Eat and Eat More! 2Health News:Candidate Potential Report Reduces Risk of Bad Hires 2Health News:Candidate Potential Report Reduces Risk of Bad Hires 3
... at University of Heidelberg in Mannheim, conclude...age more rapidly than men.// The study also states...quently as men do. This will have a revolut...d before pregnancy. It might have adverse effects ...
...ve shown that daily oral doses of Lorenzos oil can...gical disorder// called X-linked adrenoleukodystro...r Institute in Baltimore have reported that use of...e their daily doses of the oil, which is a composi...
... Drug Administration is scrutinizing the claims m...tion Bio- Germ .According to the claims made by th... can give protection from anthrax . The Bio-Germ P...ch is made from grapefruit seeds and the oil of an...
...en found to reduce the risk of cellular rejection ...ndard immunosuppression. The drug, a humanize...erleukin-2 receptor, thereby inhibiting T-cell pro...te or severe cellular rejection, hemodynamically s...
...rm of ancient Indian exercise and meditation for t...ng properties and is popularly used to relieve peo...n, trauma and anxiety in patients with breast can...ive outcome to relieve patients of pain. Now The U...
...ional study was done involving 598 068 nuclear ind...one to estimate the risk of cancer after administr...n international collaborative study to estimate th... study recruits were employed in 154 different fac...
Other Medicine News:Health News:A New Product Offering protection against anthrax 2Health News:Yoga Can Be Good For Breast Cancer Patients 2Health News:Cancer risk among nuclear industry workers 2
(Date:11/20/2009)..., , MINNEAPOLIS, Nov. 20 /PRNewswire-FirstCall...ced results for its first quarter ended September ...er diluted share, on revenues of $3,263,000. This...r diluted share, on revenues of $3,168,000 for the...he first quarter results, Biotel President and CEO...
(Date:11/20/2009)..., , FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire...(NYSE: BDX ) today announced the completion of i...chigan-based company that develops and manufacture...orms. ,, In May 2009, BD and HandyLab announced...ercialize molecular assays on the HandyLab Jaguar(...
(Date:11/19/2009)..., , ARDEE, Ireland, Nov. 19 ...ed the pricing of its previously announced seconda...t a price to the public of $22.25 per share. The ... Bain Capital Partners, DLJ Merchant Banking, J.P....mas H. Lee Partners, L.P., certain other instituti...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 1Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 2Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 3Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 4Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 5Alcohol advertising self regulation not working as ads target younger drinkers 48311 1Alcohol advertising self regulation not working as ads target younger drinkers 48311 2Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers 48309 1Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers 48309 2
...uticals, Inc.,announced today that a new analysis ... Biomedical Research Institute at Harbor-UCLA Medi...of hypogonadal men with AndroGel(R),(testosterone ...rdless of,weight and body mass index (BMI). These ...ocrine Society Annual Meeting (ENDO) in San Franci...
...ONE MINERAL DENSITY, SAN DIEGO, June 17 Neurocri...ay that the elagolix 0603 Phase IIb trial,(Petal S...he last subject,completed her Week 24 study visit ...mpact of elagolix treatment on bone mineral densit...X-ray Absorptiometry (DXA) scans to,document any c...
Other Medicine Technology:New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI 2New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI 3New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI 4Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis 2Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis 3
Lambda Fluoro 320
DELFIA Platewash
SkanStacker (110V)
...he Labcyte miniGene LW is a new plate washing syst...96 and 384 channel microplates with flat, V-shaped...with 8 or 16 channel nozzle heads. Simple LCD touc...ional plate stacker is available for the miniGene ...
Medicine Products: